Contents

Current Drug Targets, Volume 4 - Number 4

Inwardly Rectifying Potassium Channels in the Regulation of Vascular Tone

, 4(4): 281 - 289

Sophocles Chrissobolis and Christopher G. Sobey


DOI: 10.2174/1389450033491046




Endoglin (CD105): A Target for Anti-angiogenetic Cancer Therapy

, 4(4): 291 - 296

E. Fonsatti, M. Altomonte, P. Arslan and M. Maio


DOI: 10.2174/1389450033491073




Vascular and Parenchymal Mechanisms in Multiple Drug Resistance: a Lesson from Human Epilepsy

, 4(4): 297 - 304

Matteo Marroni, Nicola Marchi, Luca Cucullo, N. Joan Abbott, Kathy Signorelli and Damir Janigro


DOI: 10.2174/1389450033491109




The Molecular Targets of Antitumor 2-deoxycytidine Analogues

, 4(4): 305 - 313

Tohru Obata, Yoshio Endo, Daigo Murata, Kazuki Sakamoto and Takuma Sasaki


DOI: 10.2174/1389450033491037




Anticoagulant Therapy for Acute Lung Injury or Pneumonia

, 4(4): 315 - 321

Marcus J. Schultz, Marcel Levi and Tom van der Poll


DOI: 10.2174/1389450033491064




Zinc Homeostasis-regulating Proteins: New Drug Targets for Triggering Cell Fate

, 4(4): 323 - 338

F. Chimienti, M. Aouffen, A. Favier and M. Seve


DOI: 10.2174/1389450033491082




Gene Therapy with Transcription Factor Decoy Oligonucleotides as a Potential Treatment for Cardiovascular Diseases

, 4(4): 339 - 346

Naruya Tomita, Haruhito Azuma, Yasufumi Kaneda, Toshio Ogihara and Ryuichi Morishita


DOI: 10.2174/1389450033491055




Update on Tandem Pore (2P) Domain K+ Channels

, 4(4): 347 - 351

C. Spencer Yost


DOI: 10.2174/1389450033491091




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science